Complete Filing Data
C2 Blockchain, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of -$31.2 thousand for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean C2 Blockchain, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Income Loss | -$235.3K | -$30.0K | -$18.5K | -$8.4K | -$5.6K |
| Operating Expenses | $222.8K | $30.0K | $18.5K | $8.4K | $5.6K |
| General And Administrative Expense | $222.8K | $30.0K | $18.5K | $8.4K | $5.6K |
| Operating Income Loss | -$222.6K | -$30.0K | |||
| Revenues | $185.00 | ||||
| Nonoperating Income Expense | -$12.7K | ||||
| Interest Expense | |||||
| Other Nonoperating Income Expense | |||||
| Goodwill And Intangible Asset Impairment | -$12.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$87.5K | -$2.4M | -$100.6K | -$4.8K | -$7.8K | -$4.0K | -$4.0K | -$9.6K | -$4.9K | -$2.4K | -$4.9K | -$2.5K | -$2.3K | -$2.0K |
| Operating Expenses | $162.7K | $302.9K | $100.6K | $4.8K | $7.8K | $4.0K | $4.0K | $9.6K | $4.9K | $2.4K | $4.9K | $2.5K | $2.3K | $2.0K |
| General And Administrative Expense | $162.7K | $302.9K | $100.6K | $4.8K | $7.8K | $4.0K | $4.0K | $9.6K | $4.9K | $2.4K | $4.9K | $2.5K | $2.3K | $2.0K |
| Operating Income Loss | -$162.7K | -$302.9K | -$100.6K | -$4.8K | -$7.8K | -$4.0K | ||||||||
| Revenues | $44.00 | $13.00 | ||||||||||||
| Nonoperating Income Expense | $75.2K | -$2.1M | ||||||||||||
| Interest Expense | -$34.7K | -$642.1K | ||||||||||||
| Other Nonoperating Income Expense | -$635.0K | |||||||||||||
| Goodwill And Intangible Asset Impairment |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity * | -$61.2K | -$31.2K | -$12.7K | -$4.3K | |
| Retained Earnings Accumulated Deficit | -$62.5K | -$32.5K | -$14.0K | -$5.6K | |
| Liabilities | $61.2K | $31.2K | $12.7K | $4.3K | |
| Common Stock Value | $253.9K | $253.9K | $253.9K | ||
| Loans And Leases Receivable Allowance | $61.2K | $31.2K | $12.7K | ||
| Liabilities And Stockholders Equity | $30.00 | ||||
| Cash And Cash Equivalents At Carrying Value | $30.00 | ||||
| Assets | $30.00 | ||||
| Accrued Liabilities Current | $4.3K | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | |||||
| Cash And Cash Equivalents Period Increase Decrease | $30.00 | ||||
| Assets Current | $30.00 | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$21.00 | $30.00 | |||
| Prepaid Expense And Other Assets | |||||
| Other Intangible Assets Net | |||||
| Common Stock Share Subscribed But Unissued Subscriptions Receivable | |||||
| Cashreceivedsharesnotyetisued | $50.0K | ||||
| Cashreceivedforsharesnotyetissuedvalue | $50.0K | ||||
| Gain Loss On Investments | |||||
| Derivative Assets Liabilities At Fair Value Net | |||||
| Cashpaidcryptoperiod | |||||
| Amortization Of Debt Discount Premium |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | -$440.9K | -$628.4K | -$8.4K | -$39.4K | -$73.7K | -$69.0K | -$61.2K | -$48.7K | -$44.7K | -$40.7K | -$24.9K | -$19.9K | -$17.5K | -$11.1K | -$8.6K | -$6.3K | |
| Retained Earnings Accumulated Deficit | -$2.8M | -$2.7M | -$297.8K | -$175.7K | -$75.1K | -$70.3K | -$50.0K | -$46.0K | -$42.0K | -$26.2K | -$21.3K | -$18.9K | -$12.4K | -$9.9K | -$7.6K | ||
| Liabilities | $1.1M | $1.9M | $84.0K | $76.6K | $73.8K | $69.0K | $48.7K | $44.8K | $40.7K | $24.9K | $19.9K | $17.5K | $11.1K | $8.6K | $6.3K | ||
| Common Stock Value | $410.5K | $393.3K | $274.7K | $261.9K | $253.9K | $253.9K | $253.9K | $253.9K | $253.9K | $253.9K | $253.9K | $253.9K | |||||
| Loans And Leases Receivable Allowance | $36.6K | $73.8K | $69.0K | $48.7K | $44.8K | $40.7K | $24.9K | $19.9K | $17.5K | $8.6K | $6.3K | $4.3K | |||||
| Liabilities And Stockholders Equity | $659.7K | $1.2M | $75.6K | $37.2K | $20.00 | $60.00 | $90.00 | $0.00 | $0.00 | ||||||||
| Cash And Cash Equivalents At Carrying Value | $1.2K | $148.1K | $9.00 | $20.8K | $20.00 | $60.00 | $90.00 | ||||||||||
| Assets | $659.7K | $1.2M | $75.6K | $37.2K | $20.00 | $60.00 | $90.00 | $0.00 | $0.00 | ||||||||
| Accrued Liabilities Current | $85.0K | $107.0K | $84.0K | $40.0K | $2.5K | $2.3K | $2.0K | ||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $1.2K | $148.1K | $9.00 | $20.00 | $30.00 | ||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$30.00 | ||||||||||||||||
| Assets Current | $3.7K | $152.5K | $13.1K | $37.2K | |||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $148.1K | -$30.00 | |||||||||||||||
| Prepaid Expense And Other Assets | $2.5K | $4.4K | $13.1K | ||||||||||||||
| Other Intangible Assets Net | $597.5K | $1.1M | $62.5K | ||||||||||||||
| Common Stock Share Subscribed But Unissued Subscriptions Receivable | $75.0K | $50.0K | |||||||||||||||
| Cashreceivedsharesnotyetisued | $75.0K | ||||||||||||||||
| Cashreceivedforsharesnotyetissuedvalue | $75.0K | ||||||||||||||||
| Gain Loss On Investments | -$3.0K | ||||||||||||||||
| Derivative Assets Liabilities At Fair Value Net | $852.6K | $1.6M | |||||||||||||||
| Cashpaidcryptoperiod | -$1.5M | ||||||||||||||||
| Amortization Of Debt Discount Premium | $25.5K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$149.3K | -$30.0K | -$18.5K | -$12.7K | |
| Net Cash Provided By Used In Financing Activities | $211.8K | $30.1K | $18.5K | $12.7K | |
| Increase Decrease In Notes Payable Related Parties Current | $30.1K | $18.5K | $12.7K | ||
| Increase Decrease In Accrued Liabilities | $84.0K | -$4.3K | $4.3K | ||
| Proceeds From Issuance Or Sale Of Equity | $223.0K | ||||
| Net Cash Provided By Used In Investing Activities | -$62.5K | ||||
| Increase Decrease In Prepaid Expense | -$13.1K | ||||
| Payments To Acquire Investmentsperiod | -$62.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$271.2K | -$7.8K | -$9.6K | -$4.9K | -$4.3K |
| Net Cash Provided By Used In Financing Activities | $1.9M | $7.8K | $9.6K | $4.9K | $4.3K |
| Increase Decrease In Notes Payable Related Parties Current | $7.8K | $9.6K | $4.9K | $4.3K | |
| Increase Decrease In Accrued Liabilities | $23.0K | -$2.3K | |||
| Proceeds From Issuance Or Sale Of Equity | $1.7M | ||||
| Net Cash Provided By Used In Investing Activities | -$1.5M | ||||
| Increase Decrease In Prepaid Expense | $8.7K | ||||
| Payments To Acquire Investmentsperiod |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Weighted Average Number Of Share Outstanding Basic And Diluted | 258.6M | 253.9M | 253.9M | 63.3M | |
| Earnings Per Share Basic And Diluted | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Issued | 253.9M | 253.9M | 253.9M | 0.00 | |
| Shares Outstanding | |||||
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | ||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | ||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | ||
| Common Stock Shares Outstanding | 274.7M | 253.9M | 253.9M | 253.9M | |
| Shares Issued | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | ||||
| Stock Issued During Period Shares Issued For Services | 1.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Share Outstanding Basic And Diluted | 408.5M | 339.5M | 255.7M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | |||||||||
| Earnings Per Share Basic And Diluted | $0.00 | $-0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Common Stock Shares Issued | 455.7M | 410.5M | 393.3M | 274.7M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | 0.00 | 0.00 | |||||
| Shares Outstanding | 261.9M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | 253.9M | ||||||||
| Preferred Stock Shares Authorized | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | 20.0M | |||||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | |||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||
| Common Stock Shares Outstanding | 253.9M | 253.9M | 253.9M | 253.9M | ||||||||||||||||
| Shares Issued | 410.5M | 393.3M | 274.7M | 253.9M | 253.9M | 253.9M | ||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | ||||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | |||||||||||||||||||
| Stock Issued During Period Shares Issued For Services |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Additional Paid In Capital | -$252.6K | -$252.6K | -$252.6K | $1.3K | |
| Totalothercomprehensiveincomeloss | |||||
| Sale Of Stock Consideration Received | $223.0K | ||||
| Sharessoldperiodduration | |||||
| Other Operating Income | $185.00 | ||||
| Stakingrewards | |||||
| Sharesissuedfinancingcost | |||||
| Shareissuedloanguarantee | |||||
| Paymentstoreduceloan | -$61.2K | ||||
| Other Income | -$2.00 | ||||
| Loanrelateparty | $18.5K | $12.7K | |||
| Gain Loss Derivatives | |||||
| Derivliabilityuponnoteissuancevalueddiscountperiod | |||||
| Dayonederivativelosscharged | |||||
| Convertibleloansnetofdiscount | |||||
| Changefairvalucrypto | |||||
| Stock Issued During Period Value Issued For Services | $15.0K | ||||
| Sharespayable | |||||
| Proceedsconvertiblenotes | |||||
| Lossonchangeinfairmarketvalueofderivativeliability |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $1.9M | $1.6M | -$35.4K | -$150.6K | -$252.6K | -$252.6K | -$252.6K | -$252.6K | -$252.6K | -$252.6K | -$252.6K | -$252.6K | $1.3K | $1.3K | $1.3K |
| Totalothercomprehensiveincomeloss | -$103.6K | -$4.0K | |||||||||||||
| Sale Of Stock Consideration Received | $275.0K | $1.7M | |||||||||||||
| Sharessoldperiodduration | 17.2M | 108.6M | |||||||||||||
| Other Operating Income | $44.00 | ||||||||||||||
| Stakingrewards | $13.00 | ||||||||||||||
| Sharesissuedfinancingcost | 5.0M | ||||||||||||||
| Shareissuedloanguarantee | $5.0M | ||||||||||||||
| Paymentstoreduceloan | |||||||||||||||
| Other Income | -$491.1K | ||||||||||||||
| Loanrelateparty | |||||||||||||||
| Gain Loss Derivatives | $744.9K | ||||||||||||||
| Derivliabilityuponnoteissuancevalueddiscountperiod | $4.0K | ||||||||||||||
| Dayonederivativelosscharged | $616.6K | ||||||||||||||
| Convertibleloansnetofdiscount | $137.3K | $158.8K | |||||||||||||
| Changefairvalucrypto | $491.1K | ||||||||||||||
| Stock Issued During Period Value Issued For Services | |||||||||||||||
| Sharespayable | 28.0K | ||||||||||||||
| Proceedsconvertiblenotes | $217.0K | ||||||||||||||
| Lossonchangeinfairmarketvalueofderivativeliability | -$933.9K |
Most recent annual filing with the SEC: September 29, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.